BamSEC and AlphaSense Join Forces
Learn More

BioCorRx Inc

OTC: BICX    
Share price (11/19/24): $0.36    
Market cap (11/19/24): $4.590 million

Material Contracts Filter

EX-10.1
from 8-K 7 pages Executive Service Agreement
12/34/56
EX-10.2
from 8-K 5 pages BioCorRx Inc. Promissory Note
12/34/56
EX-10.1
from 8-K 7 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 5 pages BioCorRx Inc. Promissory Note
12/34/56
EX-10.1
from 8-K 7 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Subscription Agreement
12/34/56
EX-10.2
from 8-K 7 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 10 pages Form of Subscription Agreement
12/34/56
EX-10.15
from 10-K 14 pages Inter-Company License Agreement
12/34/56
EX-10.2
from 8-K 14 pages BioCorRx Inc. Director and Officer Indemnification Agreement
12/34/56
EX-10.1
from 8-K 8 pages Director Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Exchange Agreement
12/34/56
EX-10.1
from 8-K 11 pages Form of Subscription Agreement
12/34/56
EX-10.1
from 8-K 15 pages Biocorrx, Inc. 2022 Omnibus Securities and Incentive Plan 695,000 Shares of Common Stock
12/34/56
EX-10.15
from 10-K 10 pages Inter-Company License Agreement
12/34/56
EX-10.1
from 8-K 12 pages The Undersigned Understands That BioCorRx Inc., a Corporation Organized Under the Laws of Nevada (The “Company”), Desired to Sell Shares of Its Common Stock, Par Value $0.001 Per Share (The “Securities”), at a Purchase Price of $4.35 Per Share (The “Purchase Price”). the Undersigned Further Understands That the Securities Will Not Be Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Any Securities Law of Any State of the United States or of Any Other Jurisdiction, in Reliance Upon the Exemption From Securities Registration Afforded by Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act”), or Rule 506 of Regulation D of as Promulgated by the Securities and Exchange Commission (The “SEC”), Under the Securities Act, or Regulation S, as Promulgated by the SEC Under the Securities Act
12/34/56
EX-10.1
from 8-K 10 pages The Undersigned Understands That BioCorRx Inc., a Corporation Organized Under the Laws of Nevada (The “Company”), Desired to Sell Shares of Its Common Stock, Par Value $0.001 Per Share (The “Securities”), at a Purchase Price of $2.00 Per Share (The “Purchase Price”). the Undersigned Further Understands That the Securities Will Not Be Registered Under the Securities Act of 1933, as Amended (The “Securities Act”), or Any Securities Law of Any State of the United States or of Any Other Jurisdiction, in Reliance Upon the Exemption From Securities Registration Afforded by Section 4(a)(2) of the Securities Act of 1933, as Amended (The “Securities Act”), or Rule 506 of Regulation D of as Promulgated by the Securities and Exchange Commission (The “SEC”), Under the Securities Act, or Regulation S, as Promulgated by the SEC Under the Securities Act
12/34/56
EX-10.1
from 8-K 8 pages Director Agreement
12/34/56
EX-10.1
from 10-Q 15 pages Second Amendment to Lease
12/34/56
EX-10.2
from 8-K 2 pages Lock-Up Agreement
12/34/56